Leonard B. Weiner

Leonard B. Weiner

Infectious Disease

750 E Adams St
Syracuse, NY 13210

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Universal Newborn Screening for Congenital Cytomegalovirus Using Dried Blood Spot Specimens.

Universal Newborn Screening for Congenital Cytomegalovirus Using Dried Blood Spot Specimens.

Journal: JAMA network open

Published: January 29, 2026

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.

Journal: Journal of the Pediatric Infectious Diseases Society

Published: August 23, 2018

Idiopathic T cell lymphopenia identified in New York State Newborn Screening.

Idiopathic T cell lymphopenia identified in New York State Newborn Screening.

Journal: Clinical immunology (Orlando, Fla.)

Published: May 02, 2017

Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.

Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.

Journal: Vaccine

Published: January 09, 2017

Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants.

Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants.

Journal: Human vaccines & immunotherapeutics

Published: February 19, 2016

Re-evaluating the New Committee on Infectious Diseases Recommendations for Palivizumab Use in Premature Infants.

Re-evaluating the New Committee on Infectious Diseases Recommendations for Palivizumab Use in Premature Infants.

Journal: The Pediatric infectious disease journal

Published: June 25, 2015

Valganciclovir for symptomatic congenital cytomegalovirus disease.

Valganciclovir for symptomatic congenital cytomegalovirus disease.

Journal: The New England journal of medicine

Published: March 05, 2015

Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.

Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.

Journal: JAMA

Published: August 21, 2014

Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis.

Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis.

Journal: BMC pediatrics

Published: September 24, 2013

Newborn screening for SCID in New York State: experience from the first two years.

Newborn screening for SCID in New York State: experience from the first two years.

Journal: Journal of clinical immunology

Published: August 29, 2013

Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective.

Cost utility of palivizumab prophylaxis among pre-term infants in the United States: a national policy perspective.

Journal: Journal of medical economics

Published: May 12, 2012

Cost-effectiveness analysis of palivizumab among pre-term infant populations covered by Medicaid in the United States.

Cost-effectiveness analysis of palivizumab among pre-term infant populations covered by Medicaid in the United States.

Journal: Journal of medical economics

Published: March 23, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026